Enovis Analyst Ratings
Enovis Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/04/2023 | 18.72% | Needham | → $70 | Reiterates | Buy → Buy |
06/26/2023 | 18.72% | Needham | → $70 | Initiates Coverage On | → Buy |
05/12/2023 | 13.64% | Wells Fargo | $55 → $67 | Upgrades | Equal-Weight → Overweight |
05/05/2023 | 13.64% | Baird | $64 → $67 | Maintains | Outperform |
03/28/2023 | 10.24% | Canaccord Genuity | → $65 | Reiterates | → Buy |
02/24/2023 | 8.55% | Baird | $68 → $64 | Maintains | Outperform |
11/03/2022 | 15.33% | Baird | $73 → $68 | Maintains | Outperform |
10/26/2022 | -10.11% | Wells Fargo | $60 → $53 | Maintains | Equal-Weight |
10/12/2022 | 1.76% | Jefferies | → $60 | Initiates Coverage On | → Buy |
10/11/2022 | -3.32% | Goldman Sachs | → $57 | Initiates Coverage On | → Buy |
09/12/2022 | 15.33% | Evercore ISI Group | → $68 | Initiates Coverage On | → Outperform |
09/12/2022 | 13.64% | Canaccord Genuity | → $67 | Initiates Coverage On | → Buy |
06/28/2022 | — | Argus Research | Initiates Coverage On | → Hold | |
06/27/2022 | 15.33% | Loop Capital | → $68 | Assumes | → Buy |
06/16/2022 | 3.46% | Wells Fargo | → $61 | Initiates Coverage On | → Equal-Weight |
04/21/2022 | — | Keybanc | Downgrades | Overweight → Sector Weight |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
08/04/2023 | 18.72% | 尼德姆 | → 70 美元 | 重申 | 購買 → 購買 |
06/26/2023 | 18.72% | 尼德姆 | → 70 美元 | 啓動覆蓋開啓 | → 購買 |
05/12/2023 | 13.64% | 富國銀行 | 55 美元 → 67 美元 | 升級 | 重量相等 → 超重 |
05/05/2023 | 13.64% | 貝爾德 | 64 美元 → 67 美元 | 維護 | 跑贏大盤 |
03/28/2023 | 10.24% | Canaccord Genu | → 65 美元 | 重申 | → 購買 |
02/24/2023 | 8.55% | 貝爾德 | 68 美元 → 64 美元 | 維護 | 跑贏大盤 |
11/03/2022 | 15.33% | 貝爾德 | 73 美元 → 68 美元 | 維護 | 跑贏大盤 |
2022 年 10 月 26 日 | -10.11% | 富國銀行 | 60 美元 → 53 美元 | 維護 | 重量相等 |
2022 年 12 月 10 日 | 1.76% | 傑富瑞 | → 60 美元 | 啓動覆蓋開啓 | → 購買 |
2022 年 10 月 11 日 | -3.32% | 高盛 | → 57 美元 | 啓動覆蓋開啓 | → 購買 |
2022 年 12 月 9 日 | 15.33% | Evercore ISI 集團 | → 68 美元 | 啓動覆蓋開啓 | → 跑贏大盤 |
2022 年 12 月 9 日 | 13.64% | Canaccord Genu | → 67 美元 | 啓動覆蓋開啓 | → 購買 |
06/28/2022 | — | 阿格斯研究 | 啓動覆蓋開啓 | → 按住 | |
06/27/2022 | 15.33% | 環路資本 | → 68 美元 | 假設 | → 購買 |
06/16/2022 | 3.46% | 富國銀行 | → 61 美元 | 啓動覆蓋開啓 | → 重量相等 |
04/21/2022 | — | Keybanc | 降級 | 增持 → 行業權重 |
What is the target price for Enovis (ENOV)?
Enovis (ENOV) 的目標價格是多少?
The latest price target for Enovis (NYSE: ENOV) was reported by Needham on August 4, 2023. The analyst firm set a price target for $70.00 expecting ENOV to rise to within 12 months (a possible 18.72% upside). 12 analyst firms have reported ratings in the last year.
Needham於2023年8月4日公佈了Enovis(紐約證券交易所代碼:ENOV)的最新目標股價。該分析公司將目標股價定爲70.00美元,預計ENOV將在12個月內升至12個月內(可能上漲18.72%)。去年有12家分析公司公佈了評級。
What is the most recent analyst rating for Enovis (ENOV)?
分析師對Enovis (ENOV) 的最新評級是多少?
The latest analyst rating for Enovis (NYSE: ENOV) was provided by Needham, and Enovis reiterated their buy rating.
Enovis(紐約證券交易所代碼:ENOV)的最新分析師評級由Needham提供,Enovis重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Enovis (ENOV)?
Enovis(ENOV)的下一個分析師評級何時公佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Enovis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Enovis was filed on August 4, 2023 so you should expect the next rating to be made available sometime around August 4, 2024.
分析師在進行了廣泛的研究(包括瀏覽公開財務報表、與Enovis的高管和客戶交談以及聽取業績電話會議)後得出股票評級。大多數分析師每三個月進行一次評級,因此每家公司每年應該獲得4個評級。Enovis的最後一次評級是在2023年8月4日提交的,因此您應該預計下一個評級將在2024年8月4日左右公佈。
Is the Analyst Rating Enovis (ENOV) correct?
分析師對Enovis (ENOV) 的評級是否正確?
While ratings are subjective and will change, the latest Enovis (ENOV) rating was a reiterated with a price target of $0.00 to $70.00. The current price Enovis (ENOV) is trading at is $58.96, which is within the analyst's predicted range.
雖然評級是主觀的,會發生變化,但最新的Enovis(ENOV)評級得到重申,目標股價爲0.00美元至70.00美元。Enovis(ENOV)目前的交易價格爲58.96美元,在分析師的預測區間內。